erucamidopropyl hydroxysultaine hamilelikte güvenli mi?
No harmonised CLP reproductive classifications or SCCS/CIR flags for reproductive toxicity were identified and the CIR safety assessment of alkyl sultaines (which lists erucamidopropyl hydroxysultaine among reportable ingredients) found no reproductive hazard; peer‑reviewed reproductive/toxicokinetic studies specific to erucamidopropyl hydroxysultaine were not found. Systemic absorption from topical use is expected to be low for surfactant ingredients, so exposure is scored as low (e=1). (Sources: CIR sultaines assessment; PubChem entry; EWG summary).
Related ingredients
Frequently asked questions
- erucamidopropyl hydroxysultaine hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications or SCCS/CIR flags for reproductive toxicity were identified and the CIR safety assessment of alkyl sultaines (which lists erucamidopropyl hydroxysultaine among reportable ingredients) found no reproductive hazard; peer‑reviewed reproductive/toxicokinetic studies specific to erucamidopropyl hydroxysultaine were not found. Systemic absorption from topical use is expected to be low for surfactant ingredients, so exposure is scored as low (e=1). (Sources: CIR sultaines assessment; PubChem entry; EWG summary).
- erucamidopropyl hydroxysultaine emzirirken güvenli mi?
- Same rationale as for pregnancy: no evidence of reproductive or developmental hazard or mechanistic endocrine activity in the authoritative reviews; expected low systemic absorption from dermal cosmetic use implies low exposure to breastfed infant via milk. No studies demonstrating placental/milk transfer or nursing‑infant effects were found. (Sources: CIR sultaines assessment; PubChem; EWG).
- erucamidopropyl hydroxysultaine bebek cildi için güvenli mi?
- No infant‑specific reproductive or mechanistic hazards identified. Because baby skin (0–3 yr) has higher surface‑area‑to‑body‑weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → baby e=2). CIR/ECHA data indicate primary concerns for alkyl sultaines are irritation and potential contamination (amidoamine/DMAPA/nitrosamine), not reproductive toxicity. (Sources: CIR sultaines assessment; EWG; ECHA registration summaries).
- VeriMom erucamidopropyl hydroxysultaine nasıl puanlıyor?
- VeriMom erucamidopropyl hydroxysultaine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte erucamidopropyl hydroxysultaine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.